Daily Probiotic Supplement segmentation by application reflects the functional intent that drives consumer purchase decisions and allocates the bulk of market revenue. The largest share, approximately 45 % of total sales, is attributed to digestive‑health formulations, which are positioned to alleviate bloating, irregularity, and antibiotic‑associated disturbances. Their dominance is underpinned by robust clinical evidence and a high repeat‑purchase rate. Immune‑support products account for roughly 30 % of the market; these supplements target modulation of gut‑associated lymphoid tissue and are favored by consumers seeking seasonal protection. Women‑specific blends, comprising about 15 % of sales, incorporate strains such as Lactobacillus rhamnosus GG that address vaginal microbiome balance and hormonal fluctuations. Pediatric offerings represent the remaining 10 %, emphasizing safety, strain specificity for infant gut colonization, and palatable delivery formats. Collectively, these application segments define the market taxonomy and determine allocation of R&D resources, distribution channels, and pricing strategies within the Daily Probiotic Supplement market.